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Resistance to artemisinin derivatives, the most potent 
antimalarial drugs currently used, has emerged in Southeast 
Asia and threatens to spread to Africa. We report a case of 
malaria	in	a	man	who	returned	to	Vietnam	after	3	years	in	
Angola that did not respond to intravenous artesunate and 
clindamycin or an oral artemisinin-based combination.
Artemisinin derivatives are used in combination with other drugs for treatment of Plasmodium falciparum 
malaria. Nevertheless, P. falciparum resistance to artemisi-
nins has been recently detected in 4 countries (Cambodia, 
Thailand, Myanmar, and Vietnam) in the Greater Mekong 
subregion in Southeast Asia (1). Artemisinin resistance 
could spread from these countries to other regions, includ-
ing sub-Saharan Africa, where the incidence of malaria is 
highest, and where artemisinin resistance would have dev-
astating consequences. Increased and uncontrolled travel 
between Asia and Africa might contribute to the spread of 
artemisinin-resistant malaria parasites.
An estimated 40,000 Vietnamese workers travel annu-
ally to Angola (2), where P. falciparum malaria is the lead-
ing cause of illness and death (3,4). Over the past year, an 
increasing number of severe malaria cases have been identi-
fied among Vietnamese migrants returning from Angola (5). 
During March–mid-April 2013, five deaths from malaria 
among Vietnamese workers in Angola were reported (6–8). 
We report a case of malaria in a Vietnamese man who re-
turned from Angola and did not respond to intravenous arte-
sunate or oral artemisinin-based combination therapy.
The Study
In April 2013, a 58-year-old Vietnamese man was ad-
mitted to Bach Mai Hospital in Hanoi, Vietnam, because 
of high fever, jaundice, and lack of consciousness. Eleven 
days before hospitalization, he had returned from Saurimo 
City in Angola, where he had been working in the con-
struction industry for the past 3 years, to his home village 
in malaria-free Nam Dinh Province, 80 km from Hanoi. 
Four days after returning from Angola, he reported fatigue, 
fever with chills, and a cough. Two days later, he went to 
the local district hospital where he was given a diagnosis 
of bronchitis and received a third-generation cephalosporin 
(cefixime) and antipyretics for 3 days. Ten days after his 
arrival in Vietnam, the patient came to the emergency de-
partment of Bach Mai Hospital because of continuous high 
fever (body temperature 39°C–40°C), dyspnea, and urinary 
incontinence. He was given fosfomycin for pyelonephritis.
Because his clinical condition worsened rapidly, the 
patient was transferred the next day to the Infectious Dis-
eases Department in the same hospital because cerebral 
malaria was diagnosed. At admission to the department, 
the patient (weight 58 kg) was in a confused state and had 
a Glasgow coma score of 13/15, generalized convulsions, 
jaundice, and tachypnea (respiration rate 25 breaths/min), 
a body temperature of 38.5°C, a blood pressure of 130/80 
mm Hg, and pulse rate of 121 beats/min. Clinical examina-
tion detected hepatomegaly and cracklings in both lungs. 
Blood tests showed the following results: leukocyte count 
13.3 × 109 cells/L, hemoglobin 15.3 g/L, platelet count 20.9 
× 109/L, blood urea nitrogen 19.8 mmol/L, serum creatinine 
135 mmol/L, aspartate aminotransferase 125 IU/L, alanine 
aminotransferase 45 IU/L, C-reactive protein 16 mg/L, pro-
calcitonin >120 ng/mL; total bilirubin 116 µmol/L; direct 
bilirubin 11.5 µmol/L; and standard levels of electrolytes.
Parasite density/microliter of blood was calculated 
after counting the total number of P. falciparum tropho-
zoites/200 leukocytes and assuming a leukocyte concentra-
tion of 8,000 cells/μL. Microscopy identified P. falciparum 
trophozoites at a concentration of 378,470/µL and some 
schizonts. A chest radiograph showed bilateral pneumonia. 
Analysis of cerebrospinal fluid and a computed tomograph-
ic scan of the brain showed standard results. Tests results 
for HIV and hepatitis B surface antigen were negative.
The patient was given a diagnosis of P. falciparum 
cerebral malaria and treated with intravenous (IV) arte-
sunate (batch no. 511004; Pharbaco, Hanoi, Vietnam) (60 
mg every 12 h, loading dose 120 mg at admission) and IV 
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clindamycin (600 mg every 12 h). After 24 h of hospitaliza-
tion, the patient had a Glasgow coma score of 11, a body 
temperature of 39.7°C, and a parasite density of 329,411 
parasites/µL (Figure 1), a blood pressure of 70/40 mm Hg, 
and a respiration rate of 30 breaths/min. An ultrasound ex-
amination showed hepatomegaly and bilateral pleural ef-
fusion. At day 2 of hospitalization, the patient was treated 
with intubation and mechanical ventilation. At day 4, the 
hemoglobin level had decreased to 9.3 g/dL and the patient 
was given a blood transfusion. After 5 consecutive days of 
treatment with IV artesunate and clindamycin, the patient 
remained comatose and had continuous fever (39°C) and 
high parasite density (148,000 parasites/µL).
At day 6 of hospitalization, artesunate and clindamy-
cin were discontinued, and oral treatment with dihydroar-
temisinin (40 mg/tablet)/piperaquine (320 mg/tablet) was 
administered through a nasogastric tube for 3 days (4 tab-
lets/day the first day, then 2 tablets/day). After 3 days of 
treatment, the patient was still febrile (38.5°C) and had 
a Glasgow coma score of 12 and a parasite density of 
113,409 parasites/µL (Figure 1). Quinine (1,750 mg/day) 
and doxycycline (200 mg/day) were then administered at 
day 9 through a nasogastric tube (injectable quinine was 
not available). Twelve hours after the first dose of quinine, 
parasite density was 55,558 parasites/µL. It decreased to 
9,668 parasites/µL 72 h at day 11 after starting quinine 
treatment, when fever eventually subsided. Two days later, 
the patient regained consciousness, and at day 15 of hospi-
talization, blood slides were negative for parasites  (Figure 
1). The patient eventually recovered and was discharged 35 
days after admission.
Species-specific PCR (9) of a blood sample obtained on 
day 3 of hospitalization confirmed the diagnosis of P. falci-
parum monoinfection. Further genotyping by using nested 
PCR (merozoite surface proteins 1 and 2 repeat markers) 
and capillary electrophoresis (10) of several filter paper 
blood spots obtained during the 23 days of hospitalization 
confirmed that the patient had a polyclonal P. falciparum in-
fection with ≥2 clones. These clones might have persisted 
from admission through day 10 of hospitalization (Figure 2).
The quality of IV artesunate used was determined by 
using high-performance liquid chromatography according 
to USP34 NF29 specifications at the National Institute of 
Drug Quality Control (Hanoi, Vietnam) (http://nidqc.org.
vn/). The drug was found to be acceptable.
Conclusions
This clinical case of suspected artemisinin resistance 
originating from sub-Saharan Africa is of concern be-
cause the patient had probably been infected in Angola 
Figure	1.	Evolution	of	Plasmodium 
falciparum parasite density 
(log scale) by day after start of 
antimalaria treatments for man 
with severe malaria who returned 
from	 Angola	 to	 Vietnam	 in	 April	
2013.	 Values	 are	 parasites/
microliter	of	blood.	IV,	intravenous.
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and because the clinical presentation differed from de-
layed parasite clearance reported in Southeast Asia (1). 
The patient had never had malaria and had worked con-
tinuously in Angola for the past 3 years before his return 
(direct flight to Hanoi and then directly by car to his home 
village) to a malaria-free area in Vietnam. Given the on-
set of symptoms only 4 days after his return, the patient 
was most likely infected in Luanda Sul Province, Angola, 
to which malaria is hyperendemic and where Vietnamese 
workers have reportedly died of malaria (6–8).
Five days of treatment with intravenous artesunate and 
clindamycin and a 3-day regimen of dihydroartemisinin/
piperaquine did not clear the infection because parasite 
density remained high (>100,000 parasites/µL) until the 
eighth day of hospitalization. Parasite density showed a 
logarithmic decrease only after treatment was changed to 
quinine and doxycycline.
An external quality control of all blood slides was per-
formed by an expert microscopist at the National Institute 
of Malariology, Parasitology and Entomology in Hanoi; 
the parasite densities were confirmed. Therefore, this case 
is suggestive of P. falciparum tolerance to artemisinin de-
rivatives. However, because no blood samples for pharma-
cokinetic or in vitro studies were obtained, drug resistance 
could not be confirmed.
Identification of P. falciparum malaria parasites tolerant 
to arteminins raises serious concerns that artemisin-resistant 
strains have emerged or spread in Africa. This finding would 
be a major public health disaster and needs to be urgently 
confirmed by larger treatment efficacy studies in Angola.
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